| Authors: |
Niessen J; Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, Uppsala, Sweden., Arendt N; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden., Sjöblom M; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden., Dubbelboer IR; Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, Uppsala, Sweden., Borchardt T; Product Development Science & Technology, AbbVie Inc., North Chicago, IL, United States., Koziolek M; Small Molecule CMC Development, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany., Hedeland M; Department of Medicinal Chemistry, Analytical Pharmaceutical Chemistry, Uppsala University, Uppsala, Sweden., Lennernäs H; Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, Uppsala, Sweden., Indulkar A; Small Molecule CMC Development, Research & Development, AbbVie Inc., North Chicago, IL, United States., Dahlgren D; Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, Uppsala, Sweden. Electronic address: david.dahlgren@uu.se. |
